sensei(US:SNSE)2025-11-14 12:35Financial Results - Sensei Biotherapeutics, Inc. announced its financial results for the quarter ended September 30, 2025[4] - A press release detailing the financial results was issued on November 14, 2025[4] - The financial results include key metrics that will be detailed in the attached press release[4] - The report includes an exhibit with further financial details[6] Company Classification - The company is classified as an emerging growth company under the Securities Act[3] - The report is not deemed "filed" under the Securities Exchange Act of 1934[5] Company Information - The company is headquartered at 1405 Research Blvd, Suite 125, Rockville, MD 20850[1] - The common stock of Sensei Biotherapeutics is traded on The Nasdaq Stock Market under the symbol SNSE[2] Report Details - The report was signed by Christopher W. Gerry, General Counsel and Secretary[9] - The filing date of the report is November 14, 2025[9]